Harness your immune system to fight cancer — under the direct care of Dr. Amish Vora, Medical Oncologist | DM Oncology – AIIMS New Delhi | Ex-Tata Memorial Hospital, Mumbai | Ex-MSKCC, New York | 6,000+ Patients Treated
Cancer cells survive by disguising themselves — they produce proteins that tell your immune system, "I am normal, do not attack me." Immunotherapy removes this disguise. It either activates your immune cells directly, blocks the proteins cancer uses to hide, or engineers immune cells in a lab to target your specific cancer.
The result is an immune system that can now see the cancer and attack it. For many patients receiving immunotherapy in Delhi at H.O.P.E Oncology Clinic, this approach has delivered responses that outlast the treatment itself — something conventional chemotherapy rarely achieves.
Dr. Amish Vora uses biomarker testing — including PD-L1 expression, MSI/MMR status, and Tumour Mutational Burden (TMB) — to identify which patients will benefit most from immunotherapy, and which type is best suited to their specific cancer.
Helps your body's natural defenses recognize and attack cancer cells.
PD-L1, MSI/MMR and TMB testing to identify ideal candidates.
Every immunotherapy protocol is tailored to the patient's cancer profile.
H.O.P.E Oncology Clinic provides the following immunotherapy treatments in South Delhi, each selected based on your cancer's biology:
Drugs such as pembrolizumab (Keytruda) and nivolumab (Opdivo) block the PD-1/PD-L1 pathway — removing the "off switch" that cancer uses to hide from your immune cells. Widely used for lung cancer, head & neck cancer, stomach cancer, bladder cancer, and more. Available at H.O.P.E Oncology Clinic, Delhi.
Lab-engineered antibodies that attach to specific proteins on cancer cells — helping the immune system recognise and destroy them. Examples include trastuzumab (Herceptin) for HER2-positive breast cancer and rituximab for blood cancers. Highly precise, with fewer side effects than standard chemotherapy.
For many cancers, combining immunotherapy with chemotherapy in Delhi delivers significantly better outcomes than either treatment alone. Dr. Amish Vora designs combination protocols based on your cancer's molecular profile — maximising effectiveness while carefully managing treatment-related side effects.
Immunotherapy has transformed outcomes for advanced and metastatic cancers. For Stage 4 lung cancer, stomach cancer, and head & neck cancer, checkpoint inhibitors can extend survival and achieve durable responses. H.O.P.E Oncology Clinic, South Delhi specialises in immunotherapy for Stage 4 cancer patients across Delhi NCR.
Dr. Amish Vora provides immunotherapy treatment in Delhi NCR for the following cancer types:
NSCLC (non-small cell lung cancer), including Stage 3B and Stage 4.
Squamous cell carcinoma of the oral cavity, throat and larynx.
Especially triple-negative breast cancer (TNBC) and HER2-positive breast cancer.
Including gastroesophageal junction cancer.
Hodgkin lymphoma, non-Hodgkin lymphoma and multiple myeloma.
Urothelial carcinoma treatment with advanced immunotherapy protocols.
Immunotherapy for renal cell carcinoma and advanced kidney cancers.
Particularly effective for MSI-H and dMMR-positive patients.
Personalised immunotherapy approaches for women's cancers.
Immunotherapy as first-line, second-line, or combination treatment for advanced and metastatic cancers.
Call +91 9310839967 — Dr. Amish Vora will review your reports and advise on eligibility at your first consultation.
Call Now WhatsApp UsDr. Amish Vora personally sees every patient, reviews every scan, and makes every treatment decision. You are not passed to a junior doctor. His training at AIIMS, Tata Memorial, and MSKCC New York brings world-class immunotherapy expertise to South Delhi.
Not every patient benefits from immunotherapy. Dr. Vora recommends PD-L1, MSI, and TMB testing only when genuinely necessary — helping avoid unnecessary costs while ensuring treatment matches your tumour biology.
Most immunotherapy infusions take only 30–90 minutes. Patients receive treatment in a comfortable private setting and return home the same day without overnight hospitalisation.
If you experience immune-related side effects such as rash, breathlessness, or fatigue, our team is directly reachable. Prompt management of immunotherapy-related adverse events is a critical part of safe cancer care.
Patients visit H.O.P.E from Gurugram, Noida, Faridabad, Ghaziabad, and across Delhi NCR for immunotherapy under Dr. Vora's care. Conveniently located at A-22, Hauz Khas.
Oncology nutrition, psychological counselling, and physiotherapy services are available alongside immunotherapy — supporting the whole patient, not just treating the tumour.
Dr. Amish Vora is a senior Medical Oncologist and co-founder of H.O.P.E Oncology Clinic, Hauz Khas, New Delhi. With over 30 years of experience in medical oncology, he has personally treated more than 6,000 cancer patients and supervised over 70,000 chemotherapy and immunotherapy sessions across Delhi NCR.
Dr. Vora completed his DM in Medical Oncology from AIIMS New Delhi and subsequently trained at Tata Memorial Hospital, Mumbai — India's foremost cancer institution — and Memorial Sloan Kettering Cancer Center (MSKCC), New York, consistently ranked among the world's top three cancer centres. He is a member of ESMO (European Society of Medical Oncology) and ISMPO.
His approach to immunotherapy in Delhi is biomarker-driven: he recommends immunotherapy only when the evidence supports it for your specific cancer, and designs the protocol around your tumour's molecular profile — not a generic treatment plan.
Eligibility for immunotherapy depends on your cancer type, the results of biomarker tests (PD-L1 expression, MSI/MMR status, TMB level), and your overall health. Not every patient with cancer is a candidate — which is why a consultation with Dr. Amish Vora is essential before any decision is made. He will review your existing biopsy reports and advise on which tests, if any, are needed. Book a consultation at H.O.P.E Oncology Clinic, Hauz Khas: +91 9310839967 .
Immunotherapy cost in Delhi varies by drug type, dose, number of cycles, and whether it is combined with chemotherapy. Pembrolizumab (Keytruda) and nivolumab (Opdivo) cost differently from targeted antibodies like trastuzumab (Herceptin). H.O.P.E Oncology Clinic provides a transparent, full-programme cost estimate at your first consultation — before any treatment starts. We are empanelled with major health insurance providers. Call +91 9310839967 to check your coverage.
In the vast majority of cases, immunotherapy does not cause hair loss. This is one of the clearest differences from chemotherapy and is one of the first questions new patients ask Dr. Amish Vora at H.O.P.E Oncology Clinic. While some skin-related side effects like rash are possible, significant hair loss is not a typical feature of checkpoint inhibitor immunotherapy or monoclonal antibody treatment.
Yes. Immunotherapy is particularly valuable for Stage 4 (advanced or metastatic) cancer patients. For eligible patients, checkpoint inhibitors such as pembrolizumab have achieved durable responses in Stage 4 lung cancer, head and neck cancer, gastric cancer, and more — including cases where chemotherapy alone was insufficient. H.O.P.E Oncology Clinic, South Delhi has extensive experience treating Stage 4 cancer patients with immunotherapy and combination protocols.
Most immunotherapy infusion sessions at H.O.P.E Oncology Clinic, Hauz Khas take between 30 minutes and 2 hours, depending on the drug and protocol. Unlike chemotherapy, which can take 4–6 hours per session, immunotherapy infusions are generally shorter. Most patients receive treatment as a daycare patient and return home the same day. Sessions are scheduled at your convenience — Monday to Saturday, 9:00 AM to 8:00 PM.